Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: Stimulation by soluble CD23

Immunology

Volumn 91, Issue 4, 1997, Pages 643-648

  Roman, V ^a,d   Dugas, N ^b   Abadie, A ^a   Amirand, C ^a   Zhao, H ^a   Dugas, B ^c   Kolb, J P ^a  

^a INSTITUT CURIE   (France)

^b Lab Virus   (France)

^c Fractales Biotech   (France)

^d STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD23 ANTIGEN; INTERLEUKIN 4; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CALCIUM TRANSPORT; CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONOCYTE; PRIORITY JOURNAL;

CALCIUM; CYCLIC GMP; GENE EXPRESSION; HUMANS; MONOCYTES; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; RECEPTORS, IGE; RNA, MESSENGER; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0030841170     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.d01-2263.x     Document Type: Article

References (52)

1. MONCADA S., PALMER, R.M.J. & HIGGS E.A. (1991) Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev 43, 109.
2. NATHAN C. (1992) Nitric oxide as a secretory product of mamalian cells. FASEB J 6, 3051.
3. BREDT D.S., HWANG P.M., GLATT C.E., LOWENSTEIN C., REED R.R. & SNYDER S.H. (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351, 714.
4. NAKANE M., SCHMIDT H.H.H.W., POLLOCK J.S., FORSTERMANN U. & MURAD F. (1993) Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316, 175.
5. SESSA W.C., HARRISON J.K., BARBER C.M. et al. (1992) Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 267, 15 274.
6. MARSDEN P.A., SCHAPPERT K.T., CHEN H.S. et al. (1992) Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 307, 287.
7. BUSSE R. & MULSCH A. (1990) Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett 265, 133.
8. BREDT D. & SNYDER S.H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87, 682.
9. XIE Q., CHO H.J., CALAYCAY J. et al. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225.
10. LYONS C.R., ORLOFF G.J. & CUNNINGHAM J.M. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. J Biol Chem 267, 6370.
11. GELLER D.A., LOWENSTKIN C.J., SHAPIRO R.A. et al. (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90, 3491.
12. CHARTRAIN N.A., GELLER D.A., KOTY P.P. et al. (1994) Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase. J Biol Chem 269, 6765.
13. DENIS M. (1994) Human monocytes macrophages: NO or no NO? J Leukoc Biol 55, 682.
14. WEINBERG J.B., MISUKONIS M.A., SHAMI P.J., MASON S.N. et al. (1995) Human mononuclear hagocyte inductible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86, 1184.
15. ALBINA J.E. (1995) On the expression of nitric oxide synthase hy human macrophages. Why no NO? J Leukoc Biol 58, 643.
16. DUGAS B., MOSSALAYI D.M., DAMAIS C. & KOLB J.P. (1995) Nitric oxide production by human monocytes macrophages. Evidence for a role of CD23 Immunol Today 16, 574.
17. MIYAHARA K., KAWAMOTO T., SASE K. et al. (1994) Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem 223, 719.
18. MARSDEN P.A. HENG H.H., SCHERER S.W. et al. (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268, 17 478.
19. REILING N, ULMER A.J., DUCHROW M., ERNST M., FLAD H.D. & HAUSCHILDT S. (1994) Nitric oxide synthase: mRNA expression of different isoforms in human monocytes macrophages. Eur J Immunol 24, 1941.
20. DUGAS B., PAUL-EUGENE N., YAMAOKA K.A., AMIRAND C., DAMAIS C. & KOLB J.P. (1995) IL-4 induces cAMP and cGMP in human monocytic cells. Med Inflamm 4, 298.
21. REILING N., KRÖNCKE R., ULMER A.J., GERDES J., FLAD H.D. & HAUSCHILDT S. (1996) Nitric oxide synthase: expression of the endothelial, Ca2 +/calmodulin-dependent isoform in human B and T lymphocytes. Eur J Immunol 26, 511.
22. LECOANET-HENCHOZ S., GAUCHAT J.-F., AUBRY, J.-P. et al. (1995) CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3, 119.
23. DELESPESSE G., SUTER U., MOSSALAYI M.D. et al. (1991) Expression, structure, and function of the CD23 antigen. Adv Immunol 49, 149.
24. GORDON J. (1991) CD23: novel disease marker with a split personality. Clin Exp Immunol 86, 356.
25. BONNEFOY J.Y., AUBRY J.P., PÉRONNE C., WIJDENES J. & BANCHEREAU J. (1987) Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD23 is a low affinity receptor for IgE. J Immunol 138, 2970.
26. AUBRY J.P., POCHON S., GRABER P., JANSEN K.U. & BONNEFOY J.Y. (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358, 505.
27. HARRIS P. & RALPH P. (1985) Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol 37, 407.
28. MACDONALD R.J., SWIFT G.H., PRZYBYLA A.E. & CHIRGWIN J.M. (1987) Isolation of RNA using guanidinium salts. Methods Enzymol 152, 219.
29. PAUL-EUGENE N., MOSSALAYI M.D., SARFATI M. et al. (1995) Role of FcεRII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. Cell Immunol 163, 314.
30. VOULDOUKIS I., RIVEROS-MORENO V., DUGAS B et al. (1995) The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of FcεR11/CD23 surface antigen. Proc Natl Acad Sci USA 92, 7804.
31. IGNARRO L.J. (1990) Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol Toxicol 67, 1.
32. KOLB J.P., PAUL-EUGÈNE N., DAMAIS C., YAMAOKA K., DRAPIER J.C. & DUGAS B. (1994) IL-4 stimulates cGMP production by IFN-γ-activated human monocytes Involvement of the nitric oxide synthase pathway. J Biol Chem 269, 9811.
33. 2+]/and polyphosphoinositide hydrolysis in human activated B cells Involvement of a Gp protein. J Immunol 145, 429.
34. ROSENKRANZ-WEISS P., SESSA W.C., MILSTIEN S., KAUFMAN S., WATSON C.A. & POBER J.S. (1994) Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 93, 2236.
35. SAURA M., PEREZ-SALA D., CANADA F.J. & LAMAS S. (1996) Role of tetrahydrobiopterin availability in the regulation of nitric-oxide synthase expression in human mesangial cells. J Biol Chem 271, 14 290.
36. CHEN P.F., TSAI A.L., BERKA V. & WU K.K. (1996) Endothelial nitric- oxide synthase Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system. J Biol Chem 271, 14 631.
37. POLLOCK J.S., FORSTERMANN U., MITCHELL J.A. et al. (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 88, 10 480.
38. SESSA W.C., BARBER C.M. & LYNCH K.R. (1993) Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein Circ Res 72, 921.
39. MARTIN J.H.J. & EDWARDS S.W. (1993) Changes in mechanisms of monocyte macrophage-mediated cytotoxicity during culture: reactive oxygen intermediates in monocyte-derived cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages for tumor killing. J Immunol 150, 3478.
40. DUGAS N., MOSSALAYI M.D., CALENDA A. et al. (1996) Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1, 25-dihydroxyvitamin D3 on human promonocytic leukemic cells. Blood 88, 3528.
41. ARMANT M., ISHIHARA H., RUBIO M., DELESPESSE G. & SARFATI M. (1994) Regulation of cytokine production by soluble CD23: costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release. J Exp Med 180, 1005.
42. HERBELIN A., ELHADAD S., OUAAZ, F., DE GROOTE D. & DESCAMPSLATSCHA B. (1994) Soluble CD23 potentiates interleukin-1-induced secretion of interleukin-6 and interleukin-1 receptor antagonist by human monocytes. Eur J Immunol 24, 1869.
43. ARMANT M., RUBIO M., DELESPESSE G. & SARFATI M. (1995) Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J Immunol 155, 4868.
44. EIGLER A., SINHA B. & ENDRES S. (1993) Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Commun 196, 494.
45. MAEKAWA N., HOSOKAWA H., SOH H. et al. (1995) Serum levels of soluble CD23 in patients with bullous pemphigoid. J Dermatol 22, 310.
46. SANCHEZ-GUERRERO I., ALBALADEJO M.D., GARCIA-ALONSO A.M., MURO M., HERNANDEZ J. & ALVAREZ M.R. (1994) Soluble CD23 (sCD23) serum levels and lymphocyte subpopulations in peripheral blood in rhinitis and extrinsic and intrinsic asthma. Allergy 49, 587.
47. BANSAL A.S., MACGREGOR A.J., PUMPHREY R.S., SILMAN A.J., OLLIER W.E. & WILSON P.B. (1994) Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin Exp Rheumatol 12, 281.
48. AL-JANADI M., AL-WABEL A. & RAZIUDDIN S. (1994) Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. Clin Immunol Immunopathol 71, 33.
49. PLATER-ZYBERK C. & BONNEKOY J.Y. (1995) Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nature Med 8, 781.
50. FARRELI A.J., BLAKE D.R., PALMER R.M.J. & MONCADA S. (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51, 1219.
51. MONCADA S. & HIGGS A. (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9, 1319.
52. KING J.M., SRIVASTAVA K.D., STEFANO G.B, BILFINGER T.V., BAHOU W.F. & MAGAZINE H.I. (1997) Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J Immunol 158, 880.